Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. [electronic resource]
Producer: 20130516Description: 606-15 p. digitalISSN:- 1468-3288
- Adult
- Aged
- Aged, 80 and over
- Antibiotics, Antineoplastic -- pharmacology
- Blotting, Western
- Carcinoma, Hepatocellular -- etiology
- Case-Control Studies
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Chemoprevention -- methods
- Diabetes Mellitus, Type 2 -- drug therapy
- Dose-Response Relationship, Drug
- Doxorubicin -- pharmacology
- Female
- Humans
- Hypoglycemic Agents -- pharmacology
- In Vitro Techniques
- Liver Neoplasms -- etiology
- Male
- Metformin -- pharmacology
- Middle Aged
- RNA, Small Interfering
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.